Amir London, CEO of Kamada Pharmaceuticals, was recently a guest on Benzinga's All-Access. Kamada is a global biopharmaceutical company with a portfolio of assets indicated for rare and serious ...

Kamada Reports Strong Second Quarter and First Half 2024 Financial Results with Year-Over-Year 6-Month Top-Line Growth of 18% and a 68% Increase in Profitability Kamada Ltd. Wed, Aug 14, 2024, 7: ...

Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products ...

REHOVOT, Israel (AP) — REHOVOT, Israel (AP) — Kamada Ltd. (KMDA) on Wednesday reported fourth-quarter net income of $3.8 million. The Rehovot, Israel-based company said it had net income of 7 ...

Kamada is a global biopharmaceutical company with a portfolio of assets indicated for rare and serious conditions. The company reports it is a leader in the specialty plasma-derived field, ...